Why the study?
Electrocardiographic features of apical hypertrophic cardiomyopathy can mimic non-ST elevation acute coronary syndrome, potentially triggering unnecessary investigations and treatments.
Can specific 12-lead ECG characteristics accurately differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome?
Observational (n=113)
Single-blind
No
Can specific 12-lead ECG characteristics accurately differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome?
Specific 12-lead ECG criteria, including higher R and negative T wave voltages and greater ST-segment depression, can accurately differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome.
BACKGROUND: Apical hypertrophic cardiomyopathy (ApHCM) is a phenotypic variant of nonobstructive HCM. ApHCM is characterized by left ventricular hypertrophy involve the distal apex. The electrocardiographic character of ApHCM can mimic non-ST elevation acute coronary syndrome (NSTEACS), triggering a series of studies and treatments that may be unnecessary. This study aimed to clarify the electrocardiogram (ECG) differences between the two diseases. METHODS: Initial ECG recordings of 41 patients with ApHCM and 72 patients with NSTEACS were analyzed retrospectively. We analyzed the voltage of negative T (neg T) and R wave, the change of ST-segment as well as the number of leads with neg T wave in the 12-lead ECGs. RESULTS: Across the 12-lead ECGs, the magnitude of R wave significantly differed between ApHCM and NSTEACS in 10 leads excluding leads aVR and V1. ApHCM was associated with a greater maximal amplitude of R wave in lead V5 (3.13 ± 1.08 vs. 1.38 ± 0.73 mV, P < 0.001). The magnitude of T wave significantly differed between ApHCM and NSTEACS in 10 leads excluding leads II and V1. ApHCM was associated with a greater maximal amplitude of neg T wave in lead V4 (0.85 ± 0.69 vs. 0.35 ± 0.23 mV, P < 0.001). The frequency of giant neg T (1mv or more) wave was higher in ApHCM (36.5% vs. 0%, P < 0.001). The magnitude of ST-segment deviation significantly differed between ApHCM and NSTEACS in 10 leads excluding leads aVF and V2. ApHCM was associated with a greater maximal amplitude of ST-segment depression in lead V5 (0.19 ± 0.07 vs. 0.03 ± 0.06 mV, P < 0.001). The number of leads with neg T wave also differed between ApHCM and NSTEACS (6.75 ± 1.42 vs. 6.08 ± 1.51, P = 0.046). The sum of R wave in lead V5, neg T wave in lead V6 and ST-segment depression in lead V4 > 2.585 mV identified ApHCM with 90.2% sensibility and 87.5% specificity, representing the highest diagnostic accuracy. CONCLUSIONS: Compared with NSTEACS patients, ApHCM patients presented higher R and neg T wave voltage as well as a greater ST-segment depression in the 12-lead ECG. The ECG characteristics can help to differentiate ApHCM from NSTEACS in clinical setting.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2020) conducted an observational in Apical hypertrophic cardiomyopathy vs non-ST elevation acute coronary syndrome (n=113). Apical hypertrophic cardiomyopathy (ApHCM) vs. Non-ST elevation acute coronary syndrome (NSTEACS) was evaluated on Maximal amplitude of R wave in lead V5 (mV) (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: